
Beijing Tiantan Biological Products Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beijing Tiantan Biological Products Co Ltd
Access all reports
Beijing Tiantan Biological Products Co., Ltd. is a biopharmaceutical company that develops, manufactures, and distributes a range of blood-based and vaccine products. The company focuses on producing plasma-derived products, including treatments for immune deficiencies and blood coagulation disorders, as well as vaccines for infectious diseases. Utilizing advanced bioprocessing and quality assurance standards, Beijing Tiantan Biological aims to support healthcare needs in China and potentially in international markets. The company is involved in research to expand its product portfolio within the biologics field. Beijing Tiantan Biological Products is headquartered in Beijing, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
600161
Country
🇨🇳 China